PamGene International BV
PrivateLast Round
Series A
Apr 16, 2026
Total Funding Raised
$23.5M
Company Overview
PamGene International BV operates in Healthcare & Life Sciences and is based in 's-Hertogenbosch. Its latest recorded funding round was a Series A round in April 2026.
PamGene International BV is a biotechnology company that provides a peptide-based microarray technology for kinase activity profiling to support drug development and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PamGene International BV Comparables
Compare PamGene International BV with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pepscope | 81% | |
| RayBiotech | 79% | |
| Biosynth | 79% |
For institutional investors. Book with your work email.
PamGene International BV Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 16, 2026 | ||||
| Grant | Jun 27, 2023 |
For institutional investors. Book with your work email.
PamGene International BV Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Myosotis Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 15, 2025
Grew 16% QoQ, from 37 to 43 employees.
- Jun 27, 2023
Secured $8.2M from the European Innovation Council Fund.
For institutional investors. Book with your work email.
PamGene International BV Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PamGene International BV's valuation, stock price, and market status.
Is PamGene International BV a public or private company?
PamGene International BV is a private company.
What is the current stock price of PamGene International BV?
PamGene International BV is a private company, so its shares have no public market price. Caplight tracks PamGene International BV's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PamGene International BV worth (valuation)?
Valuation information for PamGene International BV is not publicly available.
Can I buy PamGene International BV stock?
PamGene International BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PamGene International BV's last funding round?
PamGene International BV's most recent funding round was Series A on April 16, 2026.
Who are the main investors in PamGene International BV?
Key investors in PamGene International BV include Myosotis Investments.
Will PamGene International BV IPO soon?
No public IPO plans have been announced for PamGene International BV.
How can I track PamGene International BV secondary market activity?
Caplight tracks bids, offers, and trades in PamGene International BV's shares on secondary markets.